Lab Anim Res.  2010 Jun;26(2):145-151. 10.5625/lar.2010.26.2.145.

Bex1 Participates in Muscle Regeneration by Regulating Myogenic Satellite Cell Differentiation

• Koo JH

• KMID: 2312060
• DOI: http://doi.org/10.5625/lar.2010.26.2.145

Abstract

Bex1 protein is upregulated in regenerating muscle and interacts with calmodulin, a Ca2+-binding protein involved in cell cycle regulation. Following cardiotoxin-induced injury the regenerating muscle of Bex1 knock-out mice exhibits prolonged cell proliferation and delayed cell differentiation compared to wild-type mice. To gain insight into this process, we compared the regenerating myogenic morphologies of Bex1 knock-out and wild-type mice at several time points. Bex1-positive cells were identified by double immunofluorescence staining. These studies demonstrated that a population of cells that are Bex1-positive after injury are c-Met/basal lamina-positive and Mac-1-negative indicating that they are derived from at least a subset of myogenic progenitor/satellite cells but not invading immune cells. In addition, in regenerating muscle, Bex1 co-localizes with calmodulin in the cytoplasm of the late myoblast or early myotube stage of myogenesis. These results suggest that Bex1 participates in muscle regeneration through the regulation of satellite cell proliferation and differentiation by its interaction with calmodulin. Current studies of Bex1 may provide a new molecular tool for the identification of activated satellite cell and open the way to new or improved therapeutic regimens against progressive muscular atrophy.

Keyword

Bex1; calmodulin; satellite cell; muscle regeneration

MeSH Terms

Animals
Calmodulin
Cell Cycle
Cell Differentiation
Cell Proliferation
Cytoplasm
Fluorescent Antibody Technique
Mice
Mice, Knockout
Muscle Development
Muscle Fibers, Skeletal
Muscles
Muscular Atrophy, Spinal
Myoblasts
Regeneration
Satellite Cells, Skeletal Muscle
Calmodulin

Figure

• 

  Figure 1. Cardiotoxin (CTX)-induced degeneration/regeneration shows similar histological appearances between Bex1-/- and wild type (WT) skeletal muscle by Hematoxylin and Eosin (H&E) staining. CTX was injected into the Tibialis anterior (TA) muscles of WT and Bex1-knock out (Bex1-KO) mice and harvested at 0 days, 3, 5, 7, 17 days (D) after injection. Although Bex1-KO exhibits altered muscle regeneration (Koo et al., 2007) there is no obvious visible difference in muscle morphology by H&E staining between regenerating Bex1-KO and WT.

• 

  Figure 2. Bex1 is expressed in the late myoblast or early myotube stage of myogenesis. After cardiotoxin-injury, induced expression and localization of Bex1 in regenerating muscle of wild type mice was elucidated by immunofluorescent staining with the rabbit antibody against Bex1 followed by H&E staining. The arrows indicate Bex1-positive cells and the arrowheads illustrate that Bex1 is highly expressed in nuclei. Nuclei are counterstained with DAPI ∗: Large vacuolated cells.

• 

  Figure 3. All Bex1 (+) cells are not macrophage (+) cells. The regenerating muscle cells of wild type mice after injury are identified by antibodies to Bex1 (red) and Mac-1 (green). Mac-1 staining represents inflammatory and immune cells including macrophages. Note the absence of double stained cells. Nuclei are counterstained with DAPI. ∗=the area of high magnification in panels to the right.

• 

  Figure 4. Bex1 is expressed in activated satellite cells identified with c-Met and are also surrounded by basal laminin at 4 days after CTX. Most of Bex1-positive cells are c-Met-positive cells and are surrounded by basal laminin (arrow). Nuclei are counterstained with DAPI. The arrows indicate Bex1-positive satellite cell (top arrow) surrounding by basal laminin (bottom arrow). ∗=the area of high magnification in the panel to the right.

• 

  Figure 5. Bex1 co-localizes with calmodulin (CaM) in regenerating muscle cells of wild type mice. Co-localization of Bex1 (green) and CaM (red) illustrated at 7 days after cardiotoxin (CTX)-injury. Cryostat sections of muscle taken at 7 days after CTX were double-labeled with antisera to Bex1 and to CaM and were analyzed by confocal microscopy. The figure illustrates the presence of three different stages of the cellular responses of CaM and Bex1 expression after CTX treatment. First, Bex1 occupies the entire cell with no expression of CaM (arrow), Second, Bex1 is highly expressed in the nucleus and less intensely in the cytoplasm, whereas punctate staining for CaM occupies the entire cytoplasm and is absent from the nucleus (arrowhead), thirdly, in the last case CaM is localized to the plasma membrane and virtually no Bex1 staining is observed (double arrowhead). The cytoplasm of the second type of cells demonstrates the colocalization of Bex1 and CaM, which is the most abundant pattern seen 7 days after CTX treatment (arrowhead). The cell denoted by the arrow indicates a Bex1-positive cell that is CaM-negative which is the major type seen at 4 days after CTX treatment. The double arrowhead represents the predominant type seen in regenerating muscle at 10 days after CTX treatment.

Reference

Alvarez E.., Zhou W.., Witta S.E.., Freed C.R.2005. Characterization of the Bex gene family in humans, mice, and rats. Gene. 357(1):18–28.

Behrens M.., Margolis J.W.., Margolis F.L.2003. Identification of members of the Bex gene family as olfactory marker protein (OMP) binding partners. J. Neurochem. 86(5):1289–1296.

Burghes A.H.., Logan C.., Hu X.., Belfall B.., Worton R.G.., Ray P.N.1987. A cDNA clone from the Duchenne/Becker muscular dystrophy gene. Nature. 328(6129):434–437.

Charge S.B.., Rudnicki M.A.2004. Cellular and molecular regulation of muscle regeneration. Physiol. Rev. 84(1):209–238.

Cornelison D.D.., Wold B.J.1997. Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells. Dev. Biol. 191(2):270–283.

Cornelison D.D.., Filla M.S.., Stanley H.M.., Rapraeger A.C.., Olwin B.B.2001. Syndecan-3 and syndecan-4 specifically mark skeletal muscle satellite cells and are implicated in satellite cell maintenance and muscle regeneration. Dev. Biol. 239(1):79–94.

Cossu G.., Mavilio F.2000. Myogenic stem cells for the therapy of primary myopathies: wishful thinking or therapeutic perspective? J. Clin. Invest. 105(12):1669–1674.

Dhawan J.., Rando T.A.2005. Stem cells in postnatal myogenesis: molecular mechanisms of satellite cell quiescence, activation and replenishment. Trends Cell Biol. 15(12):666–673.

Floss T.., Arnold H.H.., Braun T.1997. A role for FGF-6 in skeletal muscle regeneration. Genes Dev. 11(16):2040–2051.

Garry D.J.., Yang Q.., Bassel-Duby R.., Williams R.S.1997. Persistent expression of MNF identifies myogenic stem cells in postnatal muscles. Dev. Biol. 188(2):280–294.

Garry D.J.., Meeson A.., Elterman J.., Zhao Y.., Yang P.., Bassel-Duby R.., Williams R.S.2000. Myogenic stem cell function is impaired in mice lacking the forkhead/winged helix protein MNF. Proc. Natl. Acad. Sci. USA. 97(10):5416–5421.

Grady R.M.., Teng H.., Nichol M.C.., Cunningham J.C.., Wilkinson R.S.., Sanes J.R.1997. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell. 90(4):729–738.

Goetsch S.C.., Hawke T.J.., Gallardo T.D.., Richardson J.A.., Garry D.J.2003. Transcriptional profiling and regulation of the extracellular matrix during muscle regeneration. Physiol. Genomics. 14(3):261–271.

Hawke T.J.., Garry D.J.2001. Myogenic satellite cells: physiology to molecular biology. J. Appl. Physiol. 91(2):534–551.

Heslop L.., Morgan J.E.., Partridge T.A.2000. Evidence for a myogenic stem cell that is exhausted in dystrophic muscle. J. Cell Sci. 113(12):2299–2308.

Koo J.H.., Saraswati M.., Margolis F.L.2005. Immunolocalization of Bex protein in the mouse brain and olfactory system. J. Comp. Neurol. 487(1):1–14.

Koo J.H.., Smiley M.A.., Lovering R.M.., Margolis F.L.2007. Bex1 knock out mice show altered skeletal muscle regeneration. Biochem. Biophys. Res. Commun. 363(2):405–410.

Morgan J.E.., Partridge T.A.2003. Muscle satellite cells. Int. J. Biochem. Cell Biol. 35(8):1151–1156.

Orimo S.., Hiyamuta E.., Arahata K.., Sugita H.1991. Analysis of inflammatory cells and complement C3 in bupivacaine-induced myonecrosis. Muscle Nerve. 14(6):515–520.

Schmalbruch H.., Lewis D.M.2000. Dynamics of nuclei of muscle fibers and connective tissue cells in normal and denervated rat muscles. Muscle Nerve. 23(4):617–626.

Tidball J.G.., Berchenko E.., Frenette J.1999. Macrophage invasion does not contribute to muscle membrane injury during inflammation. J. Leukoc. Biol. 65(4):492–498.

Vilar M.., Murillo-Carretero M.., Mira H.., Magnusson K.., Besset V.., Ibáñez C.F.2006. Bex1, a novel interactor of the p75 neurotrophin receptor, links neurotrophin signaling to the cell cycle. EMBO J. 25(6):1219–1230.

Yan Z.., Choi S.., Liu X.., Zhang M.., Schageman J.J.., Lee S.Y.., Hart R.., Lin L.., Thurmond F.A.., Williams R.S.2003. Highly coordinated gene regulation in mouse skeletal muscle regeneration. J. Biol. Chem. 278(10):8826–8836.